Enhancing Astrocyte Neuroprotective Functions Using P53 Isoforms Read more about Enhancing Astrocyte Neuroprotective Functions Using P53 Isoforms US Application 62/190,644Filed on 2015-07-09
ANTIBODY-DRUG CONJUGATES FOR TARGETING CD56-POSITIVE TUMORS Read more about ANTIBODY-DRUG CONJUGATES FOR TARGETING CD56-POSITIVE TUMORS US Application 62/199,707Filed on 2015-07-31
Mesothelin-Targeted Chimeric Antigen Receptors and Uses Thereof Read more about Mesothelin-Targeted Chimeric Antigen Receptors and Uses Thereof US Application 62/008,851Filed on 2014-06-06
Methods of Characterizing Adrenocortical Tumors Read more about Methods of Characterizing Adrenocortical Tumors US Application 62/186,218Filed on 2015-06-29
Fixatives and Methods of Use Read more about Fixatives and Methods of Use US Application 62/255,030Filed on 2015-11-13
Generation Of Anti-Idiotype Therapeutics For B-cell Malignancies Read more about Generation Of Anti-Idiotype Therapeutics For B-cell Malignancies US Application 62/173,318Filed on 2015-06-09
Pseudomonas Exotoxin A with Modified Furin Cleavage Site Read more about Pseudomonas Exotoxin A with Modified Furin Cleavage Site US Application 62/163,667Filed on 2015-05-19
Methods For The Treatment Or Prevention of Ischemic Tissue Damage Read more about Methods For The Treatment Or Prevention of Ischemic Tissue Damage US Application 62/160,836Filed on 2015-05-13
Synthetic Immunosuppressive Oligodeoxynucleotides Reduce Ischemic Tissue Damage Read more about Synthetic Immunosuppressive Oligodeoxynucleotides Reduce Ischemic Tissue Damage US Application 62/160,828Filed on 2015-05-13
Anti-Mutated Kras T Cell Receptors Read more about Anti-Mutated Kras T Cell Receptors US Application 62/171,321Filed on 2015-06-05